About Forkhead box protein L2
Forkhead box protein L2 (FOXL2) is a protein
from Homo sapiens identified by UniProt accession
P58012, 376 residues long.
MolForge cross-references it against 0 known binders and
273 disease associations.
Target properties
| Protein name | Forkhead box protein L2 |
| UniProt accession | P58012 |
| Gene | FOXL2 |
| Organism | Homo sapiens |
| Length | 376 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (273)
Diseases linked to this target (Open Targets).
- blepharophimosis, ptosis, and epicanthus inversus syndrome · score 0.83
- primary ovarian insufficiency · score 0.72
- blepharophimosis-ptosis-epicanthus inversus syndrome type 2 · score 0.60
- genetic non-acquired premature ovarian failure · score 0.44
- genetic disorder · score 0.41
- Ovarian Granulosa Cell Tumor · score 0.37
- ovarian epithelial tumor · score 0.37
- Ovarian Sertoli-Leydig Cell Tumor · score 0.37
- neurodegenerative disease · score 0.34
- non-small cell lung carcinoma · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P58012-F1 | alphafold | PREDICTED | 60.13 | — |
Amino-acid sequence (376 residues)
MMASYPEPED AAGALLAPET GRTVKEPEGP PPSPGKGGGG GGGTAPEKPD PAQKPPYSYV ALIAMAIRES AEKRLTLSGI YQYIIAKFPF YEKNKKGWQN SIRHNLSLNE CFIKVPREGG GERKGNYWTL DPACEDMFEK GNYRRRRRMK RPFRPPPAHF QPGKGLFGAG GAAGGCGVAG AGADGYGYLA PPKYLQSGFL NNSWPLPQPP SPMPYASCQM AAAAAAAAAA AAAAGPGSPG AAAVVKGLAG PAASYGPYTR VQSMALPPGV VNSYNGLGGP PAAPPPPPHP HPHPHAHHLH AAAAPPPAPP HHGAAAPPPG QLSPASPATA APPAPAPTSA PGLQFACARQ PELAMMHCSY WDHDSKTGAL HSRLDL
Explore Forkhead box protein L2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets